Issues of Adherence to Immunosuppressant Therapy After Solid-Organ Transplantation

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.4, 2002-04, pp. : 567-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate mofetil in solid-organ transplantation

By Srinivas Titte R Kaplan Bruce Meier-Kriesche Herwig-Ulf

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2325-2345

Informa Healthcare

Access to resources Recommend Favorite

Management of Cytomegalovirus Infection after Solid-Organ or Stem-Cell Transplantation: Current Guidelines and Future Prospects

By Hebart H.

Drugs, Vol. 55, Iss. 1, 1998-01 ,pp. : 59-72

Adis International

Access to resources Recommend Favorite

Managing Post-Transplant Lymphoproliferative Disorders in Solid-Organ Transplant Recipients: A Review of Immunosuppressant Regimens

By Murukesan Vidhya

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1631-1643

Adis International

Access to resources Recommend Favorite

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

By Eid Albert J. Razonable Raymund R.

Drugs, Vol. 70, Iss. 8, 2010-05 ,pp. : 965-981

Adis International

Access to resources Recommend Favorite

Sepsis and Solid Organ Transplantation

Current Drug Targets, Vol. 8, Iss. 4, 2007-04 ,pp. : 533-541

Bentham Science Publishers

Access to resources Recommend Favorite